Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 257-263

  Dejong, Cornelis H C ^a,b   Busquets, Sylvia ^c   Moses, Alastair G W ^b   Schrauwen, Patrick ^a   Ross, Jim A ^b   Argiles, Josep M ^c   Fearon, Kenneth C H ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cachexia; Inflammation; Muscle; Pancreatic cancer; Ubiquitin proteasome pathway; Uncoupling proteins

Indexed keywords

C REACTIVE PROTEIN; CARRIER PROTEIN; INTERLEUKIN 6; ION CHANNEL; MEMBRANE PROTEIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; MITOCHONDRIAL UNCOUPLING PROTEIN 3; PROTEASOME; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN;

AGED; ARTICLE; BLOOD; BODY HEIGHT; BODY WEIGHT; CACHEXIA; COMPARATIVE STUDY; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; NORTHERN BLOTTING; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLUBILITY; STATISTICS; WESTERN BLOTTING;

AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; BODY HEIGHT; BODY WEIGHT; C-REACTIVE PROTEIN; CACHEXIA; CARRIER PROTEINS; ENERGY METABOLISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERLEUKIN-6; ION CHANNELS; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; PANCREATIC NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOLUBILITY; STATISTICS; UBIQUITIN;

EID: 24644450343     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Fearon KCH, Falconer JS, Slater C, McMillan DC, Ross JA and Preston T: Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute phase protein response. Ann Surg 227: 249-254, 1998. (Pubitemid 28087919)
2. Wigmore SJ, Plester CE, Richardson RA and Fearon KCH: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75: 106-109, 1997. (Pubitemid 27007281)
3. Wigmore SJ, Plester CE, Ross JA and Fearon KCH: Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84: 196-197, 1997. (Pubitemid 27073460)
4. Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG and Tisdale MJ: Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 85: 297-302, 2001. (Pubitemid 32695755)
5. Weigle DS, Selfridge LE, Schwartz MW, et al: Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47: 298-302, 1998. (Pubitemid 28079993)
6. Flier JS and Lowell BB: Obesity research springs a proton leak. Nat Genet 15: 223-224, 1997. (Pubitemid 27098711)
7. Dulloo AG and Samec S: Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered. Br J Nutr 86: 123-139, 2001. (Pubitemid 32780616)
8. Giordano A, Calvani M, Petillo O, Carteni M, Melone MR and Peluso G: Skeletal muscle metabolism in physiology and in cancer disease. J Cell Biochem 90: 170-186, 2003. (Pubitemid 37052319)
9. Fleury C, Neverova M, Collins S, et al: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15: 269-272, 1997. (Pubitemid 27098720)
10. Boss O, Samec S, Paolini-Giacobino A, et al: Uncoupling protein 3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408: 39-42, 1997. (Pubitemid 27216458)
11. Millet L, Vidal H, Andreelli F, et al: Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 100: 2665-2670, 1997. (Pubitemid 28007533)
12. Sanchis D, Busquets S, Alvarez B, Ricquier D, Lopez-Soriano FJ and Argiles JM: Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model. FEBS Lett 436: 415-418, 1998. (Pubitemid 28482973)
13. Busquets S, Sanchis D, Alvarez B, Ricquier D, Lopez-Soriano FJ and Argiles JM: In the rat, tumor necrosis factor alpha administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis? FEBS Lett 440: 348-350, 1998. (Pubitemid 29052312)
14. Tiao G, Fagan JM, Samuels N, et al: Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 94: 2255-2264, 1994. (Pubitemid 24379596)
15. Price SR: Increased transcription of ubiquitin-proteasome system components: molecular responses associated with muscle atrophy. Int J Biochem Cell Biol 35: 617-628, 2003.
16. Williams A, Sun X, Fischer JE and Hasselgren PO: The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 126: 744-749, 1999.
17. Bossola M, Muscaritoli M, Costelli P, et al: Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol 280: R1518-R1523, 2001.
18. Cancer AJCo: AJJC Cancer Staging Manual. 5th edition. Philadelphia: Lippincott Williams & Wilkins, 1997.
19. Llovera M, Garcia-Martinez C, Agell N, Marzabal M, Lopez-Soriano FJ and Argiles JM: Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett 338: 311-318, 1994. (Pubitemid 24056743)
20. Bond U and Schlesinger MJ: Ubiquitin is a heat shock protein in chicken embryo fibroblasts. Mol Cell Biol 5: 949-956, 1985. (Pubitemid 15110282)
21. Hesselink MK, Keizer HA, Borghouts LB, et al: Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers. FASEB J 15: 1071-1073, 2001.
22. Schrauwen P, Schaart G, Saris WH, et al: The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects. Diabetologia 43: 1408-1416, 2000.
23. Chen WJ and Chung YC: Energy expenditure in patients with hepatocellular carcinoma. Cancer 73: 590-595, 1994.
24. Hansell DT, Davies JW and Burns HJ: Effects of hepatic metastases on resting energy expenditure in patients with colorectal cancer. Br J Surg 73: 659-662, 1986. (Pubitemid 16039372)
25. Fredrix EW, Wouters EF, Soeters PB, et al: Resting energy expenditure in patients with non-small cell lung cancer. Cancer 68: 1616-1621, 1991.
26. Hasselgren P-O and Fischer JE: The ubiquitin-proteasome pathway. Review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann Surg 225: 307-316, 1997. (Pubitemid 27131568)
27. Bosutti A, Biolo G, Toigo G, et al: Molecular regulation of protein catabolism in trauma patients. Clin Nutr 18: 103-105, 1999. (Pubitemid 29237910)
28. Busquets S, Garcia-Martinez C, Alvarez B, Carbo N, Lopez-Soriano FJ and Argiles JM: Calpain-3 gene expression is decreased during experimental cancer cachexia. Biochim Biophys Acta 1475: 5-9, 2000. (Pubitemid 30259232)
29. Mitch WE and Goldberg AL: Mechanism of muscle wasting. The role of the ubiquitin-proteasome pathway. New Engl J Med 335: 1897-1905, 1996. (Pubitemid 26419198)
30. Bossola M, Muscaritoli M, Costelli P, et al: Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 237: 384-389, 2003. (Pubitemid 38176454)
31. Jagoe RT, Redfern CP, Roberts RG, Gibson GJ and Goodship TH: Skeletal muscle mRNA levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy. Clin Sci 102: 353-361, 2002. (Pubitemid 34214399)
32. Palmer RM and Thompson MG: Potential intracellular targets for anabolic/anticatabolic therapies. Curr Opin Clin Nutr Metab Care 2: 213-218, 1999. (Pubitemid 129627820)
33. McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA and You M: Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 8: 1127-1138, 2002. (Pubitemid 35177366)
34. Lazarus DD, Destree AT, Mazzola LM, et al: A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway. Am J Physiol 277: E332-E341, 1999. (Pubitemid 29413840)
35. Collins P, Bing C, McCulloch P and Williams G: Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans. Br J Cancer 86: 372-375, 2002. (Pubitemid 34185120)
36. Argyropoulos G, Brown AM, Willi SM, et al: Effects of mutations in the uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest 102: 1345-1351, 1998. (Pubitemid 28467562)
37. Schrauwen P, Hesselink MK, Blaak EE, et al: Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 50: 2870-2873, 2001. (Pubitemid 33733141)
38. Arsenijevic D, Onuma H, Pecqueur C, et al: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26: 435-439, 2000.
39. Argiles JM and Lopez-Soriano FJ: The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci 17: 223-226, 1996. (Pubitemid 26191244)
40. Fearon KC and Moses AG: Cancer cachexia. Int J Cardiol 85: 73-81, 2002.
41. Barber MD, Ross JA and Fearon KC: Cancer cachexia. Surg Oncol 8: 133-141, 1999. Development